Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem Pharmacol
2019 Jan 01;159:140-153. doi: 10.1016/j.bcp.2018.11.018.
Show Gene links
Show Anatomy links
The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.
Sapkota K
,
Dore K
,
Tang K
,
Irvine M
,
Fang G
,
Burnell ES
,
Malinow R
,
Jane DE
,
Monaghan DT
.
???displayArticle.abstract???
N-methyl-d-aspartate receptors (NMDARs) have multiple prominent roles in CNS function but their excessive or insufficient activity contributes to neuropathological/psychiatric disorders. Consequently, a variety of positive and negative allosteric modulators (PAMs and NAMs, respectively) have recently been developed. Although these modulators bind to extracellular domains, in the present report we find that the NMDAR's intracellular C-terminal domains (CTDs) significantly influence PAM/NAM activity. GluN2 CTD deletion robustly affected NAM and PAM activity with both enhancing and inhibiting effects that were compound-specific and NMDAR subunit-specific. In three cases, individual PAMs became NAMs at specific GluN2-truncated receptors. In contrast to GluN2, GluN1 CTD removal only reduced PAM activity of UBP684 and CIQ, and did not affect NAM activity. Consistent with these findings, agents altering phosphorylation state or intracellular calcium levels displayed receptor-specific and compound-specific effects on PAM activity. It is possible that the GluN2's M4 domain transmits intracellular modulatory signals from the CTD to the M1/M4 channel gating machinery and that this site is a point of convergence in the direct or indirect actions of several PAMs/NAMs thus rendering them sensitive to CTD status. Thus, allosteric modulators are likely to have a marked and varied sensitivity to post-translational modifications, protein-protein associations, and intracellular ions. The interaction between PAM activity and NMDAR CTDs appears reciprocal. GluN1 CTD-deletion eliminated UBP684, but not pregnenolone sulfate (PS), PAM activity. And, in the absence of agonists, UBP684, but not PS, was able to promote movement of fluorescently-tagged GluN1-CTDs. Thus, it may be possible to pharmacologically target NMDAR metabotropic activity in the absence of channel activation.
Acker,
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
2011, Pubmed
Acker,
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
2011,
Pubmed
Aman,
Separate intramolecular targets for protein kinase A control N-methyl-D-aspartate receptor gating and Ca2+ permeability.
2014,
Pubmed
Amin,
Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors.
2017,
Pubmed
Bajaj,
Identification of an atypical calcium-dependent calmodulin binding site on the C-terminal domain of GluN2A.
2014,
Pubmed
Bettini,
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
2010,
Pubmed
Buller,
The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
1994,
Pubmed
,
Xenbase
Burnell,
Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.
2019,
Pubmed
Chen,
Regulation of NMDA receptors by phosphorylation.
2007,
Pubmed
Choi,
Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists.
1988,
Pubmed
Chopra,
Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu.
2015,
Pubmed
Chopra,
A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors.
2017,
Pubmed
,
Xenbase
Collingridge,
The NMDA receptor as a target for cognitive enhancement.
2013,
Pubmed
Coyle,
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia.
2003,
Pubmed
Dingledine,
The glutamate receptor ion channels.
1999,
Pubmed
Dore,
Agonist binding to the NMDA receptor drives movement of its cytoplasmic domain without ion flow.
2015,
Pubmed
Doré,
FRET-FLIM investigation of PSD95-NMDA receptor interaction in dendritic spines; control by calpain, CaMKII and Src family kinase.
2014,
Pubmed
Ehlers,
Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit.
1996,
Pubmed
Hackos,
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
2016,
Pubmed
Hansen,
Structure, function, and allosteric modulation of NMDA receptors.
2018,
Pubmed
Hardingham,
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.
2010,
Pubmed
Hayashi,
Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking.
2009,
Pubmed
Horak,
Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
2006,
Pubmed
Huggins,
The function of the amino terminal domain in NMDA receptor modulation.
2005,
Pubmed
Kalia,
NMDA receptors in clinical neurology: excitatory times ahead.
2008,
Pubmed
Kantrowitz,
Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.
2010,
Pubmed
Kazi,
Asynchronous movements prior to pore opening in NMDA receptors.
2013,
Pubmed
Kew,
An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.
1998,
Pubmed
Khatri,
Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
2014,
Pubmed
,
Xenbase
Koutsilieri,
Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
2007,
Pubmed
Krupp,
Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors.
1999,
Pubmed
Krupp,
Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors.
2002,
Pubmed
Kussius,
Pregnanolone sulfate promotes desensitization of activated NMDA receptors.
2009,
Pubmed
Lerma,
Spermine regulates N-methyl-D-aspartate receptor desensitization.
1992,
Pubmed
Li,
Developmental decrease in NMDA receptor desensitization associated with shift to synapse and interaction with postsynaptic density-95.
2003,
Pubmed
Lin,
PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating.
2006,
Pubmed
,
Xenbase
Lisman,
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
2008,
Pubmed
Lussier,
Dynamic Regulation of N-Methyl-d-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by Posttranslational Modifications.
2015,
Pubmed
Majewska,
Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?
1987,
Pubmed
Maki,
C-terminal domains of N-methyl-D-aspartic acid receptor modulate unitary channel conductance and gating.
2012,
Pubmed
Maki,
Two serine residues on GluN2A C-terminal tails control NMDA receptor current decay times.
2013,
Pubmed
Malayev,
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
2002,
Pubmed
,
Xenbase
Mayer,
Structure and function of glutamate receptor ion channels.
2004,
Pubmed
McGurk,
Polyamines potentiate responses of N-methyl-D-aspartate receptors expressed in xenopus oocytes.
1990,
Pubmed
,
Xenbase
Mody,
NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release.
1995,
Pubmed
Mohrmann,
Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
2002,
Pubmed
Monaghan,
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
2012,
Pubmed
Monaghan,
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.
1989,
Pubmed
Mullasseril,
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
2010,
Pubmed
Ogden,
Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase
Ogden,
New advances in NMDA receptor pharmacology.
2011,
Pubmed
Paoletti,
NMDA receptor subunits: function and pharmacology.
2007,
Pubmed
Petrovic,
Pregnenolone sulfate modulation of N-methyl-D-aspartate receptors is phosphorylation dependent.
2009,
Pubmed
Puddifoot,
Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes.
2009,
Pubmed
,
Xenbase
Punnakkal,
Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function.
2012,
Pubmed
Ren,
Interactions among positions in the third and fourth membrane-associated domains at the intersubunit interface of the N-methyl-D-aspartate receptor forming sites of alcohol action.
2012,
Pubmed
Sapkota,
Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
2017,
Pubmed
,
Xenbase
Sapkota,
GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
2016,
Pubmed
Sigel,
Protein kinase C transiently activated heteromeric N-methyl-D-aspartate receptor channels independent of the phosphorylatable C-terminal splice domain and of consensus phosphorylation sites.
1994,
Pubmed
,
Xenbase
Sornarajah,
NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95.
2008,
Pubmed
Steiner,
Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity.
2008,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Twomey,
Structural Mechanisms of Gating in Ionotropic Glutamate Receptors.
2018,
Pubmed
Vissel,
A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux.
2001,
Pubmed
Volkmann,
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit.
2016,
Pubmed
,
Xenbase
Wang,
Roles of subunit phosphorylation in regulating glutamate receptor function.
2014,
Pubmed
Watkins,
The glutamate story.
2006,
Pubmed
Wilding,
Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
2016,
Pubmed
Yelshanskaya,
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.
2016,
Pubmed
Yi,
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
2016,
Pubmed
,
Xenbase
Yu,
Inhibition of GluN2A-containing N-methyl-D-aspartate receptors by 2-naphthoic acid.
2013,
Pubmed
Zhao,
Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits.
2016,
Pubmed
Zheng,
Probing the Structural Dynamics of the NMDA Receptor Activation by Coarse-Grained Modeling.
2017,
Pubmed
,
Xenbase
